My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 173

    1.

    An evaluation of cost sharing to finance a diet and physical activity intervention to prevent diabetes.

    Ackermann RT, Marrero DG, Hicks KA, Hoerger TJ, Sorensen S, Zhang P, Engelgau MM, Ratner RE, Herman WH.

    Diabetes Care. 2006 Jun;29(6):1237-41.PMID: 16732002 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.

    Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, Hamman RF, Ackermann RT, Engelgau MM, Ratner RE; Diabetes Prevention Program Research Group.

    Ann Intern Med. 2005 Mar 1;142(5):323-32.PMID: 15738451 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.

    Eddy DM, Schlessinger L, Kahn R.

    Ann Intern Med. 2005 Aug 16;143(4):251-64.PMID: 16103469 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes.

    Diabetes Prevention Program Research Group.

    Diabetes Care. 2003 Sep;26(9):2518-23.PMID: 12941712 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Lifestyle interventions are cost-effective in people with different levels of diabetes risk: results from a modeling study.

    Jacobs-van der Bruggen MA, Bos G, Bemelmans WJ, Hoogenveen RT, Vijgen SM, Baan CA.

    Diabetes Care. 2007 Jan;30(1):128-34.PMID: 17192345 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom.

    Palmer AJ, Roze S, Valentine WJ, Spinas GA, Shaw JE, Zimmet PZ.

    Clin Ther. 2004 Feb;26(2):304-21.PMID: 15038953 [PubMed - indexed for MEDLINE]Related articles

    7.

    Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis.

    Gillies CL, Lambert PC, Abrams KR, Sutton AJ, Cooper NJ, Hsu RT, Davies MJ, Khunti K.

    BMJ. 2008 May 24;336(7654):1180-5. Epub 2008 Apr 21.PMID: 18426840 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program.

    Hernan WH, Brandle M, Zhang P, Williamson DF, Matulik MJ, Ratner RE, Lachin JM, Engelgau MM; Diabetes Prevention Program Research Group.

    Diabetes Care. 2003 Jan;26(1):36-47.PMID: 12502656 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Cost-effectiveness of full medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes.

    Rosen AB, Hamel MB, Weinstein MC, Cutler DM, Fendrick AM, Vijan S.

    Ann Intern Med. 2005 Jul 19;143(2):89-99.PMID: 16027450 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults.

    Hoerger TJ, Hicks KA, Sorensen SW, Herman WH, Ratner RE, Ackermann RT, Zhang P, Engelgau MM.

    Diabetes Care. 2007 Nov;30(11):2874-9. Epub 2007 Aug 13.PMID: 17698614 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Economic evaluation of therapeutic interventions to prevent Type 2 diabetes in Canada.

    Caro JJ, Getsios D, Caro I, Klittich WS, O'Brien JA.

    Diabet Med. 2004 Nov;21(11):1229-36.PMID: 15498090 [PubMed - indexed for MEDLINE]Related articles

    12.

    Cost effectiveness of community-based physical activity interventions.

    Roux L, Pratt M, Tengs TO, Yore MM, Yanagawa TL, Van Den Bos J, Rutt C, Brownson RC, Powell KE, Heath G, Kohl HW 3rd, Teutsch S, Cawley J, Lee IM, West L, Buchner DM.

    Am J Prev Med. 2008 Dec;35(6):578-88.PMID: 19000846 [PubMed - indexed for MEDLINE]Related articles

    13.

    Cost-effectiveness and cost-utility of insulin glargine compared with NPH insulin based on a 10-year simulation of long-term complications with the Diabetes Mellitus Model in patients with type 2 diabetes in Switzerland.

    Brändle M, Azoulay M, Greiner RA.

    Int J Clin Pharmacol Ther. 2007 Apr;45(4):203-20.PMID: 17474539 [PubMed - indexed for MEDLINE]Related articles

    14.

    The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study.

    Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, Li H, Li H, Jiang Y, An Y, Shuai Y, Zhang B, Zhang J, Thompson TJ, Gerzoff RB, Roglic G, Hu Y, Bennett PH.

    Lancet. 2008 May 24;371(9626):1783-9.PMID: 18502303 [PubMed - indexed for MEDLINE]Related articles

    15.

    An update on the Diabetes Prevention Program.

    Ratner RE; Diabetes Prevention Program Research.

    Endocr Pract. 2006 Jan-Feb;12 Suppl 1:20-4. Review.PMID: 16627375 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Cost-effectiveness of the interventions in the primary prevention of diabetes among Asian Indians: within-trial results of the Indian Diabetes Prevention Programme (IDPP).

    Ramachandran A, Snehalatha C, Yamuna A, Mary S, Ping Z.

    Diabetes Care. 2007 Oct;30(10):2548-52. Epub 2007 Aug 1.PMID: 17670917 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Lifestyle intervention to prevent diabetes: intensive and cost effective.

    Wylie-Rosett J, Herman WH, Goldberg RB.

    Curr Opin Lipidol. 2006 Feb;17(1):37-44.PMID: 16407714 [PubMed - indexed for MEDLINE]Related articles

    18.

    Cost-effectiveness of lifestyle modification in diabetic patients.

    Jacobs-van der Bruggen MA, van Baal PH, Hoogenveen RT, Feenstra TL, Briggs AH, Lawson K, Feskens EJ, Baan CA.

    Diabetes Care. 2009 Aug;32(8):1453-8. Epub 2009 May 12.PMID: 19435958 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The cost-effectiveness of testing for hepatitis C in former injecting drug users.

    Castelnuovo E, Thompson-Coon J, Pitt M, Cramp M, Siebert U, Price A, Stein K.

    Health Technol Assess. 2006 Sep;10(32):iii-iv, ix-xii, 1-93.PMID: 16948891 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Screening for type 2 diabetes: literature review and economic modelling.

    Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, Williams R, John A.

    Health Technol Assess. 2007 May;11(17):iii-iv, ix-xi, 1-125. Review.PMID: 17462167 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity